Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7617935 | 0.93 | ALDH1A1 (0.46) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL13951792 | 0.89 | ALDH1A1 (0.50) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL433915 | 0.89 | ALDH1A1 (0.52) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL671032 | 0.87 | ALDH1A1 (0.55) | ALDH1A1KMT2AKDM4EMEN1RECQL | |
| SCHEMBL30768206 | 0.87 | CYSLTR2 (0.49) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL7608942 | 0.87 | CYSLTR2 (0.49) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL409572 | 0.85 | SLC37A4 (0.45) | POLBALDH1A1KMT2ATDP1GAA | |
| SCHEMBL30768218 | 0.85 | ALDH1A1 (0.52) | ALDH1A1KMT2ATDP1GAAKDM4E | |
| SCHEMBL8081850 | 0.85 | ALDH1A1 (0.52) | ALDH1A1KMT2ATDP1GAAKDM4E | |
| SCHEMBL8098022 | 0.85 | CXCR5 (0.38) | POLBALDH1A1KMT2ATDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8663801-B1 | Organic-inorganic nanocomposite and polymer resin comprising the same | KOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY (KR) | 2014-03-04 | — | — | US | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| US-6395077-B1 | INKS WITH BENZOYLBENZOIC ACID AND COLORS | XEROX CORPORATION | 2002-05-28 | — | — | US | claimed |
| CN-116060124-B | Oil-soluble organic metal salt composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118173765-A | Composite lithium iron manganese phosphate positive electrode material, and preparation method and application thereof | 曲靖市德方纳米科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-116060125-B | Cobalt-molybdenum bimetal organic salt composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-116060130-B | Organic molybdenum salt composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117720923-A | Europium and yttrium co-doped calcium fluoride nano particle, composite membrane material and preparation method | 西安文理学院 | 2024-03-19 | — | — | CN | disclosed |
| US-11873295-B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | PETRA PHARMA CORPORATION (US) | 2024-01-16 | — | — | US | disclosed |
| EP-3971228-B1 | POLYAMIDE RESIN COMPOSITION | UNITIKA LTD (JP) | 2023-09-27 | — | — | EP | disclosed |
| CN-116367571-A | Electroluminescent device, method of manufacturing the same, display apparatus including the same, and layered structure | 三星电子株式会社 | 2023-06-30 | — | — | CN | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
| EP-0043185-B1 | METHOD FOR PRODUCTION OF TITANIUM HALIDE CATALYST COMPONENT, CATALYST SYSTEM INCLUDING SUCH COMPONENT, AND POLYMERIZATION OF ALPHA-OLEFINS USING SUCH SYSTEM | STAUFFER CHEMICAL COMPANY (US) | 1984-10-10 | — | — | EP | disclosed |
| EP-0040711-B1 | TITANIUM HALIDE CATALYST FOR POLYMERIZATION | STAUFFER CHEMICAL COMPANY (US) | 1983-09-28 | — | — | EP | disclosed |
| US-4347160-A | Titanium halide catalyst system | STAUFFER CHEMICAL COMPANY (US) | 1982-08-31 | — | — | US | disclosed |
| US-4325836-A | Novel titanium halide containing catalyst | STAUFFER CHEMICAL COMPANY (US) | 1982-04-20 | — | — | US | disclosed |
| EP-0043185-A1 | Method for production of titanium halide catalyst component, catalyst system including such component, and polymerization of alpha-olefins using such system | STAUFFER CHEMICAL COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| EP-0040711-A1 | Titanium halide catalyst for polymerization | STAUFFER CHEMICAL COMPANY (US) | 1981-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873295-B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | PIK3CA, PIK3R4, PIK3R5 | POLB 4192/4885ALDH1A1 3412/4885KMT2A 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.